Harvard Medical School, Boston (United States of America)
Membership:
ESC Professional Member
Follow
Contributor content
Presentation
RNA interference therapy targeting hepatic angiotensinogen for the treatment of hypertension and cardiovascular disease: a first-in-human and proof-of-concept study
